About: covid:PMC7446981

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7446981 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Baker, David Orkin, Chloe Bogner, Johannes Underwood, Mark Smith, Kimberly Angelis, Konstantinos Gartland, Martin Kahl, Lesley Khuong-Josses, Marie-Aude Matthews, Jessica Nascimento, Maria-Claudia Parks, David Rubio, Rafael Vandermeulen, Kati Wang, Ruolan Wynne, Brian van Wyk, Jean
is schema:about of	named entity 'Virologic Failure' named entity 'dolutegravir' named entity 'Food and Drug Administration' named entity 'INSTI' named entity 'rilpivirine' named entity 'rilpivirine' named entity 'virologic' named entity 'estimated glomerular filtration rate' named entity 'tenofovir disoproxil fumarate' named entity 'rilpivirine' named entity 'RNA' named entity 'rilpivirine' named entity 'triglycerides' named entity 'serum' named entity 'rilpivirine' named entity 'phenotypic assay' named entity 'dolutegravir' named entity 'reverse transcriptase' named entity 'rilpivirine' named entity 'NRTIs' named entity 'integrase' named entity 'HIV-1' named entity 'rilpivirine' named entity 'dolutegravir' named entity 'RNA' named entity 'rilpivirine' named entity 'significance level' named entity 'HIV-1 infection' named entity 'rilpivirine' named entity 'antiretroviral drugs' named entity 'CD4+ cell' named entity 'statistically significant' named entity 'sign test' named entity 'dolutegravir' named entity 'tenofovir disoproxil fumarate' named entity 'genotypic' named entity 'HIV-1' named entity 'tenofovir disoproxil fumarate' named entity 'RNA' named entity 'dolutegravir' named entity 'integrase inhibitor' named entity 'reverse transcriptase' named entity 'virologic' named entity 'HIV-1' named entity 'emtricitabine' named entity 'rilpivirine' named entity 'follow-up' named entity 'integrase' named entity 'biomarkers' named entity 'osteocalcin' named entity 'virologic failure' named entity 'HIV-1' named entity 'RNA' named entity 'drug-drug interactions' named entity 'virologic' named entity 'HIV-1' named entity 'drug resistance' named entity 'long-term' named entity 'urine' named entity 'lamivudine' named entity 'statistically significantly' named entity 'retinol-binding protein' named entity 'virologic' named entity 'phenotypic' named entity 'Monogram Biosciences' named entity 'integrase' named entity '0.01' named entity 'HIV-1' named entity 'randomly assigned' named entity 'lost to follow-up' named entity 'NRTIs' named entity 'HIV-1' named entity 'NRTI' named entity 'urine' named entity 'retinol-binding protein' named entity 'CDC' named entity 'Kaposi' named entity 'proviral' named entity 'informed consent' named entity 'dolutegravir' named entity '95% confidence interval' named entity 'dolutegravir' named entity '0.9'

Attributes

Values

Creator

Baker, David
Orkin, Chloe
Bogner, Johannes
Underwood, Mark
Smith, Kimberly
Angelis, Konstantinos
Gartland, Martin
Kahl, Lesley
Khuong-Josses, Marie-Aude
Matthews, Jessica
Nascimento, Maria-Claudia
Parks, David
Rubio, Rafael
Vandermeulen, Kati
Wang, Ruolan
Wynne, Brian
van Wyk, Jean

is schema:about of

named entity 'Virologic Failure'
named entity 'dolutegravir'
named entity 'Food and Drug Administration'
named entity 'INSTI'
named entity 'rilpivirine'
named entity 'rilpivirine'
named entity 'virologic'
named entity 'estimated glomerular filtration rate'
named entity 'tenofovir disoproxil fumarate'
named entity 'rilpivirine'
named entity 'RNA'
named entity 'rilpivirine'
named entity 'triglycerides'
named entity 'serum'
named entity 'rilpivirine'
named entity 'phenotypic assay'
named entity 'dolutegravir'
named entity 'reverse transcriptase'
named entity 'rilpivirine'
named entity 'NRTIs'
named entity 'integrase'
named entity 'HIV-1'
named entity 'rilpivirine'
named entity 'dolutegravir'
named entity 'RNA'
named entity 'rilpivirine'
named entity 'significance level'
named entity 'HIV-1 infection'
named entity 'rilpivirine'
named entity 'antiretroviral drugs'
named entity 'CD4+ cell'
named entity 'statistically significant'
named entity 'sign test'
named entity 'dolutegravir'
named entity 'tenofovir disoproxil fumarate'
named entity 'genotypic'
named entity 'HIV-1'
named entity 'tenofovir disoproxil fumarate'
named entity 'RNA'
named entity 'dolutegravir'
named entity 'integrase inhibitor'
named entity 'reverse transcriptase'
named entity 'virologic'
named entity 'HIV-1'
named entity 'emtricitabine'
named entity 'rilpivirine'
named entity 'follow-up'
named entity 'integrase'
named entity 'biomarkers'
named entity 'osteocalcin'
named entity 'virologic failure'
named entity 'HIV-1'
named entity 'RNA'
named entity 'drug-drug interactions'
named entity 'virologic'
named entity 'HIV-1'
named entity 'drug resistance'
named entity 'long-term'
named entity 'urine'
named entity 'lamivudine'
named entity 'statistically significantly'
named entity 'retinol-binding protein'
named entity 'virologic'
named entity 'phenotypic'
named entity 'Monogram Biosciences'
named entity 'integrase'
named entity '0.01'
named entity 'HIV-1'
named entity 'randomly assigned'
named entity 'lost to follow-up'
named entity 'NRTIs'
named entity 'HIV-1'
named entity 'NRTI'
named entity 'urine'
named entity 'retinol-binding protein'
named entity 'CDC'
named entity 'Kaposi'
named entity 'proviral'
named entity 'informed consent'
named entity 'dolutegravir'
named entity '95% confidence interval'
named entity 'dolutegravir'
named entity '0.9'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software